Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients

NCT03341741 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03341741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03341741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients
Lead sponsor
University Hospital Tuebingen
Phase
Phase 3
Overall status
Completed
Start date
March 11, 2014
Completion date
November 25, 2016
Enrollment
26 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis with pulmonary manifestations